Homocysteine and myocardial infarction

Five (24%) subjects out of a group of 21 men, 48–58 years old (mean 54), who had suffered their first myocardial infarction (MI) before the age of 55 and with a low risk profile vis-à-vis conventional risk factors in a health screening preceding the MI, had abnormally high total plasma homocysteine...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Atherosclerosis 1988-06, Vol.71 (2), p.227-233
Hauptverfasser: Israelsson, Bo, Brattström, Lars E., Hultberg, Björn L.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 233
container_issue 2
container_start_page 227
container_title Atherosclerosis
container_volume 71
creator Israelsson, Bo
Brattström, Lars E.
Hultberg, Björn L.
description Five (24%) subjects out of a group of 21 men, 48–58 years old (mean 54), who had suffered their first myocardial infarction (MI) before the age of 55 and with a low risk profile vis-à-vis conventional risk factors in a health screening preceding the MI, had abnormally high total plasma homocysteine values in the fasting state when investigated within 1–7 years (mean 3) after their MI. The patient group was exactly matched with 36 control subjects for sex, age, diastolic blood pressure, smoking, and serum concentrations of cholesterol and triglycerides. Total plasma homocysteine was negatively correlated to both erythrocyte folate and serum vitamin B 12, and vitamin concentrations below the median of the normal distribution were found in the five with high plasma homocysteine content, indicating a possible involvement of reduced remethylation of plasma homocysteine to methionine. After methionine loading, in 3 of the patient group (14%) homocysteine levels exceeded mean + 2 SD for controls, which may indicate heterozygosity for homocystinuria. Results are consistent with the hypothesis that a high plasma homocysteine content may be a risk factor for MI.
doi_str_mv 10.1016/0021-9150(88)90147-5
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_78338835</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>0021915088901475</els_id><sourcerecordid>78338835</sourcerecordid><originalsourceid>FETCH-LOGICAL-c386t-b631bc155958169a0f47b8b6bed56b4f4fb2681eb5fc42ab51be458c94a0495e3</originalsourceid><addsrcrecordid>eNp9kEFLAzEUhIMotVb_gUIPUvSwmreb7CYXQYpaoeBFzyHJvkBkd6PJVui_d9eWHj29w3wzvBlCLoHeAYXyntIcMgmc3ghxKymwKuNHZAqikhkwwY7J9ICckrOUPimlrAIxIZOCUchlMSWLVWiD3aYefYdz3dXzdhusjrXXzdx3Tkfb-9CdkxOnm4QX-zsjH89P78tVtn57eV0-rjNbiLLPTFmAscC55AJKqaljlRGmNFjz0jDHnMlLAWi4syzXhoNBxoWVTFMmORYzstjlfsXwvcHUq9Yni02jOwybpCpRFEIUfADZDrQxpBTRqa_oWx23Cqga51FjdzV2V0Kov3nUaLva529Mi_XBtN9j0K_3uk5WNy7qzvp0wCpgAFIO2MMOw2GLH49RJeuxs1j7iLZXdfD___ELPdB_bw</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>78338835</pqid></control><display><type>article</type><title>Homocysteine and myocardial infarction</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals</source><creator>Israelsson, Bo ; Brattström, Lars E. ; Hultberg, Björn L.</creator><creatorcontrib>Israelsson, Bo ; Brattström, Lars E. ; Hultberg, Björn L.</creatorcontrib><description>Five (24%) subjects out of a group of 21 men, 48–58 years old (mean 54), who had suffered their first myocardial infarction (MI) before the age of 55 and with a low risk profile vis-à-vis conventional risk factors in a health screening preceding the MI, had abnormally high total plasma homocysteine values in the fasting state when investigated within 1–7 years (mean 3) after their MI. The patient group was exactly matched with 36 control subjects for sex, age, diastolic blood pressure, smoking, and serum concentrations of cholesterol and triglycerides. Total plasma homocysteine was negatively correlated to both erythrocyte folate and serum vitamin B 12, and vitamin concentrations below the median of the normal distribution were found in the five with high plasma homocysteine content, indicating a possible involvement of reduced remethylation of plasma homocysteine to methionine. After methionine loading, in 3 of the patient group (14%) homocysteine levels exceeded mean + 2 SD for controls, which may indicate heterozygosity for homocystinuria. Results are consistent with the hypothesis that a high plasma homocysteine content may be a risk factor for MI.</description><identifier>ISSN: 0021-9150</identifier><identifier>EISSN: 1879-1484</identifier><identifier>DOI: 10.1016/0021-9150(88)90147-5</identifier><identifier>PMID: 3401293</identifier><language>eng</language><publisher>Amsterdam: Elsevier Ireland Ltd</publisher><subject>Atherosclerosis (general aspects, experimental research) ; Biological and medical sciences ; Blood and lymphatic vessels ; Cardiology. Vascular system ; Cystathionine beta-Synthase - deficiency ; Folate ; Folic Acid - blood ; Folic Acid - metabolism ; Heterozygote ; Homocysteine ; Homocystine - blood ; Homocystine - metabolism ; Humans ; Male ; Medical sciences ; Methionine ; Middle Aged ; Myocardial infarction ; Myocardial Infarction - blood ; Myocardial Infarction - enzymology ; Myocardial Infarction - etiology ; Retrospective Studies ; Risk Factors ; Vitamin B 12 ; Vitamin B 12 - blood ; Vitamin B 12 - metabolism</subject><ispartof>Atherosclerosis, 1988-06, Vol.71 (2), p.227-233</ispartof><rights>1988</rights><rights>1989 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c386t-b631bc155958169a0f47b8b6bed56b4f4fb2681eb5fc42ab51be458c94a0495e3</citedby><cites>FETCH-LOGICAL-c386t-b631bc155958169a0f47b8b6bed56b4f4fb2681eb5fc42ab51be458c94a0495e3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.sciencedirect.com/science/article/pii/0021915088901475$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,776,780,3537,27901,27902,65306</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=7141199$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/3401293$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Israelsson, Bo</creatorcontrib><creatorcontrib>Brattström, Lars E.</creatorcontrib><creatorcontrib>Hultberg, Björn L.</creatorcontrib><title>Homocysteine and myocardial infarction</title><title>Atherosclerosis</title><addtitle>Atherosclerosis</addtitle><description>Five (24%) subjects out of a group of 21 men, 48–58 years old (mean 54), who had suffered their first myocardial infarction (MI) before the age of 55 and with a low risk profile vis-à-vis conventional risk factors in a health screening preceding the MI, had abnormally high total plasma homocysteine values in the fasting state when investigated within 1–7 years (mean 3) after their MI. The patient group was exactly matched with 36 control subjects for sex, age, diastolic blood pressure, smoking, and serum concentrations of cholesterol and triglycerides. Total plasma homocysteine was negatively correlated to both erythrocyte folate and serum vitamin B 12, and vitamin concentrations below the median of the normal distribution were found in the five with high plasma homocysteine content, indicating a possible involvement of reduced remethylation of plasma homocysteine to methionine. After methionine loading, in 3 of the patient group (14%) homocysteine levels exceeded mean + 2 SD for controls, which may indicate heterozygosity for homocystinuria. Results are consistent with the hypothesis that a high plasma homocysteine content may be a risk factor for MI.</description><subject>Atherosclerosis (general aspects, experimental research)</subject><subject>Biological and medical sciences</subject><subject>Blood and lymphatic vessels</subject><subject>Cardiology. Vascular system</subject><subject>Cystathionine beta-Synthase - deficiency</subject><subject>Folate</subject><subject>Folic Acid - blood</subject><subject>Folic Acid - metabolism</subject><subject>Heterozygote</subject><subject>Homocysteine</subject><subject>Homocystine - blood</subject><subject>Homocystine - metabolism</subject><subject>Humans</subject><subject>Male</subject><subject>Medical sciences</subject><subject>Methionine</subject><subject>Middle Aged</subject><subject>Myocardial infarction</subject><subject>Myocardial Infarction - blood</subject><subject>Myocardial Infarction - enzymology</subject><subject>Myocardial Infarction - etiology</subject><subject>Retrospective Studies</subject><subject>Risk Factors</subject><subject>Vitamin B 12</subject><subject>Vitamin B 12 - blood</subject><subject>Vitamin B 12 - metabolism</subject><issn>0021-9150</issn><issn>1879-1484</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1988</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9kEFLAzEUhIMotVb_gUIPUvSwmreb7CYXQYpaoeBFzyHJvkBkd6PJVui_d9eWHj29w3wzvBlCLoHeAYXyntIcMgmc3ghxKymwKuNHZAqikhkwwY7J9ICckrOUPimlrAIxIZOCUchlMSWLVWiD3aYefYdz3dXzdhusjrXXzdx3Tkfb-9CdkxOnm4QX-zsjH89P78tVtn57eV0-rjNbiLLPTFmAscC55AJKqaljlRGmNFjz0jDHnMlLAWi4syzXhoNBxoWVTFMmORYzstjlfsXwvcHUq9Yni02jOwybpCpRFEIUfADZDrQxpBTRqa_oWx23Cqga51FjdzV2V0Kov3nUaLva529Mi_XBtN9j0K_3uk5WNy7qzvp0wCpgAFIO2MMOw2GLH49RJeuxs1j7iLZXdfD___ELPdB_bw</recordid><startdate>19880601</startdate><enddate>19880601</enddate><creator>Israelsson, Bo</creator><creator>Brattström, Lars E.</creator><creator>Hultberg, Björn L.</creator><general>Elsevier Ireland Ltd</general><general>Elsevier</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>19880601</creationdate><title>Homocysteine and myocardial infarction</title><author>Israelsson, Bo ; Brattström, Lars E. ; Hultberg, Björn L.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c386t-b631bc155958169a0f47b8b6bed56b4f4fb2681eb5fc42ab51be458c94a0495e3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1988</creationdate><topic>Atherosclerosis (general aspects, experimental research)</topic><topic>Biological and medical sciences</topic><topic>Blood and lymphatic vessels</topic><topic>Cardiology. Vascular system</topic><topic>Cystathionine beta-Synthase - deficiency</topic><topic>Folate</topic><topic>Folic Acid - blood</topic><topic>Folic Acid - metabolism</topic><topic>Heterozygote</topic><topic>Homocysteine</topic><topic>Homocystine - blood</topic><topic>Homocystine - metabolism</topic><topic>Humans</topic><topic>Male</topic><topic>Medical sciences</topic><topic>Methionine</topic><topic>Middle Aged</topic><topic>Myocardial infarction</topic><topic>Myocardial Infarction - blood</topic><topic>Myocardial Infarction - enzymology</topic><topic>Myocardial Infarction - etiology</topic><topic>Retrospective Studies</topic><topic>Risk Factors</topic><topic>Vitamin B 12</topic><topic>Vitamin B 12 - blood</topic><topic>Vitamin B 12 - metabolism</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Israelsson, Bo</creatorcontrib><creatorcontrib>Brattström, Lars E.</creatorcontrib><creatorcontrib>Hultberg, Björn L.</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Atherosclerosis</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Israelsson, Bo</au><au>Brattström, Lars E.</au><au>Hultberg, Björn L.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Homocysteine and myocardial infarction</atitle><jtitle>Atherosclerosis</jtitle><addtitle>Atherosclerosis</addtitle><date>1988-06-01</date><risdate>1988</risdate><volume>71</volume><issue>2</issue><spage>227</spage><epage>233</epage><pages>227-233</pages><issn>0021-9150</issn><eissn>1879-1484</eissn><abstract>Five (24%) subjects out of a group of 21 men, 48–58 years old (mean 54), who had suffered their first myocardial infarction (MI) before the age of 55 and with a low risk profile vis-à-vis conventional risk factors in a health screening preceding the MI, had abnormally high total plasma homocysteine values in the fasting state when investigated within 1–7 years (mean 3) after their MI. The patient group was exactly matched with 36 control subjects for sex, age, diastolic blood pressure, smoking, and serum concentrations of cholesterol and triglycerides. Total plasma homocysteine was negatively correlated to both erythrocyte folate and serum vitamin B 12, and vitamin concentrations below the median of the normal distribution were found in the five with high plasma homocysteine content, indicating a possible involvement of reduced remethylation of plasma homocysteine to methionine. After methionine loading, in 3 of the patient group (14%) homocysteine levels exceeded mean + 2 SD for controls, which may indicate heterozygosity for homocystinuria. Results are consistent with the hypothesis that a high plasma homocysteine content may be a risk factor for MI.</abstract><cop>Amsterdam</cop><pub>Elsevier Ireland Ltd</pub><pmid>3401293</pmid><doi>10.1016/0021-9150(88)90147-5</doi><tpages>7</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0021-9150
ispartof Atherosclerosis, 1988-06, Vol.71 (2), p.227-233
issn 0021-9150
1879-1484
language eng
recordid cdi_proquest_miscellaneous_78338835
source MEDLINE; Elsevier ScienceDirect Journals
subjects Atherosclerosis (general aspects, experimental research)
Biological and medical sciences
Blood and lymphatic vessels
Cardiology. Vascular system
Cystathionine beta-Synthase - deficiency
Folate
Folic Acid - blood
Folic Acid - metabolism
Heterozygote
Homocysteine
Homocystine - blood
Homocystine - metabolism
Humans
Male
Medical sciences
Methionine
Middle Aged
Myocardial infarction
Myocardial Infarction - blood
Myocardial Infarction - enzymology
Myocardial Infarction - etiology
Retrospective Studies
Risk Factors
Vitamin B 12
Vitamin B 12 - blood
Vitamin B 12 - metabolism
title Homocysteine and myocardial infarction
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-07T06%3A10%3A38IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Homocysteine%20and%20myocardial%20infarction&rft.jtitle=Atherosclerosis&rft.au=Israelsson,%20Bo&rft.date=1988-06-01&rft.volume=71&rft.issue=2&rft.spage=227&rft.epage=233&rft.pages=227-233&rft.issn=0021-9150&rft.eissn=1879-1484&rft_id=info:doi/10.1016/0021-9150(88)90147-5&rft_dat=%3Cproquest_cross%3E78338835%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=78338835&rft_id=info:pmid/3401293&rft_els_id=0021915088901475&rfr_iscdi=true